Japan Cell And Gene Therapy Cdmo Market Size & Outlook
The cell and gene therapy cdmo market in Japan is expected to reach a projected revenue of US$ 1,999.3 million by 2030. A compound annual growth rate of 28.8% is expected of Japan cell and gene therapy cdmo market from 2024 to 2030. In terms of segment, pre-clinical was the largest revenue generating by phase in 2023. Pre-clinical is the most lucrative by phase segment registering the fastest growth during the forecast period.